K. Öberg

2.7k total citations · 1 hit paper
33 papers, 2.1k citations indexed

About

K. Öberg is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, K. Öberg has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Neurology and 13 papers in Oncology. Recurrent topics in K. Öberg's work include Neuroendocrine Tumor Research Advances (16 papers), Neuroblastoma Research and Treatments (15 papers) and Lung Cancer Research Studies (12 papers). K. Öberg is often cited by papers focused on Neuroendocrine Tumor Research Advances (16 papers), Neuroblastoma Research and Treatments (15 papers) and Lung Cancer Research Studies (12 papers). K. Öberg collaborates with scholars based in Sweden, United Kingdom and United States. K. Öberg's co-authors include Tommy Öberg, A Karsznia, Barbro Eriksson, Philippe Ruszniewski, Martyn Caplin, WW de Herder, Eugene A. Woltering, Guido Rindi, Larry K. Kvols and Bertram Wiedenmann and has published in prestigious journals such as Radiology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

K. Öberg

32 papers receiving 2.0k citations

Hit Papers

Basic gait parameters: reference data for normal subjects... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Öberg Sweden 16 910 808 738 491 423 33 2.1k
Simone Thomas Germany 21 292 0.3× 470 0.6× 161 0.2× 312 0.6× 248 0.6× 67 1.9k
Luca Landoni Italy 29 666 0.7× 1.5k 1.9× 305 0.4× 768 1.6× 32 0.1× 99 3.1k
Marco Paoloni Italy 29 138 0.2× 128 0.2× 407 0.6× 495 1.0× 199 0.5× 142 2.7k
Michael O. Harris‐Love United States 23 1.1k 1.2× 62 0.1× 368 0.5× 197 0.4× 75 0.2× 56 2.8k
Takashi Yokoi Japan 26 141 0.2× 522 0.6× 79 0.1× 377 0.8× 79 0.2× 128 2.9k
Martin Lemay Canada 24 110 0.1× 94 0.1× 173 0.2× 173 0.4× 149 0.4× 86 2.0k
Sun Gun Chung South Korea 22 210 0.2× 64 0.1× 301 0.4× 263 0.5× 70 0.2× 99 1.8k
Satoshi Tanaka Japan 24 231 0.3× 55 0.1× 222 0.3× 276 0.6× 71 0.2× 211 2.4k
Ruí Vaz Portugal 24 220 0.2× 113 0.1× 607 0.8× 158 0.3× 41 0.1× 137 1.9k
L. Miller United States 11 152 0.2× 1.1k 1.3× 102 0.1× 183 0.4× 70 0.2× 13 1.8k

Countries citing papers authored by K. Öberg

Since Specialization
Citations

This map shows the geographic impact of K. Öberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Öberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Öberg more than expected).

Fields of papers citing papers by K. Öberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Öberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Öberg. The network helps show where K. Öberg may publish in the future.

Co-authorship network of co-authors of K. Öberg

This figure shows the co-authorship network connecting the top 25 collaborators of K. Öberg. A scholar is included among the top collaborators of K. Öberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Öberg. K. Öberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öberg, K., Andrea Califano, Jonathan Strosberg, et al.. (2020). A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. Annals of Oncology. 31(2). 202–212. 84 indexed citations
2.
Lapuerta, Pablo, M. Kulke, Martyn Caplin, et al.. (2017). Long-term survival of patients with carcinoid syndrome in clinical trials of telotristat ethyl. Annals of Oncology. 28. v147–v148. 1 indexed citations
3.
Wolin, Edward M., Beth Chasen, Matthew H. Kulke, et al.. (2017). Improved time to quality of life deterioration in patients with progressive midgut neuroendocrine tumors treated with 177Lu-DOTATATE: The NETTER-1 phase III trial. Annals of Oncology. 28. v146–v146. 4 indexed citations
4.
Strosberg, Jonathan, Edward M. Wolin, Matthew H. Kulke, et al.. (2016). NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysis. Annals of Oncology. 27. vi137–vi137. 2 indexed citations
5.
Öberg, K. & S. Jelić. (2009). Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up. Annals of Oncology. 20. iv150–iv153. 62 indexed citations
6.
Örlefors, Håkan, Anders Sundín, K. Öberg, et al.. (2005). Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 33(1). 60–65. 63 indexed citations
7.
Öberg, K.. (2004). Treatment of neuroendocrine tumours of the gastrointestinal tract. 27(4). 1 indexed citations
8.
Örlefors, Håkan, Anders Sundín, K. Öberg, et al.. (2003). Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo–tumor visualization using positron emission tomography with 11C-harmine. Nuclear Medicine and Biology. 30(6). 669–679. 30 indexed citations
9.
Öberg, K.. (2000). State of the art and future prospects in the management of neuroendocrine tumors.. PubMed. 44(1). 3–12. 37 indexed citations
10.
Öberg, K.. (1999). Neuroendocrine gastrointestinal tumors - A condensed overview of diagnosis and treatment. Annals of Oncology. 10. S3–S8. 101 indexed citations
11.
Öberg, K., et al.. (1999). Maximum isometric trunk muscle strength and activity at trunk axial rotation during sitting. Applied Ergonomics. 30(6). 515–525. 13 indexed citations
12.
Öberg, K., et al.. (1998). Torque resistance of the passive tissues of the trunk at axial rotation. Applied Ergonomics. 29(2). 111–118. 20 indexed citations
13.
Eriksson, Barbro, Håkan Örlefors, Anders Sundin, et al.. (1998). [PET in neuroendocrine tumors].. PubMed. 113(9). 308–12. 1 indexed citations
14.
Åhlström, Håkan, B. Eriksson, Mats Bergström, et al.. (1995). Pancreatic neuroendocrine tumors: diagnosis with PET.. Radiology. 195(2). 333–337. 89 indexed citations
15.
Henriksen, Rudi, Erik Wilander, & K. Öberg. (1995). Expression and prognostic significance of Bcl-2 in ovarian tumours. British Journal of Cancer. 72(5). 1324–1329. 105 indexed citations
16.
Öberg, Tommy, A Karsznia, & K. Öberg. (1993). Basic gait parameters: reference data for normal subjects, 10-79 years of age.. PubMed. 30(2). 210–23. 671 indexed citations breakdown →
17.
Öberg, K.. (1991). Cost-benefits in orthopaedic technology by using thermoplastics in developing countries. Prosthetics and Orthotics International. 15(1). 18–22. 6 indexed citations
18.
Öberg, K. & Barbro Eriksson. (1991). The Role of Interferons in the Management of Carcinoid Tumors. Acta Oncologica. 30(4). 519–522. 87 indexed citations
19.
Olsson, Erik, K. Öberg, & T. Ribbe. (1986). A computerized method for clinical gait analysis of floor reaction forces and joint angular motion. Journal of Rehabilitation Medicine. 18(3). 93–99. 10 indexed citations
20.
Kolstad, Kurt, Anders Wigren, & K. Öberg. (1982). Gait Analysis with an Angle Diagram Technique:Application in Healthy Persons and in Studies of Marmor Knee Arthroplasties. Acta Orthopaedica Scandinavica. 53(5). 733–743. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026